Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Content
    • Current
    • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Clinical Spectrum and Outcomes of Neonatal Necrotizing Enterocolitis

PRZEMYSŁAW GAŁĄZKA, MAGDALENA CHRZANOWSKA and JAN STYCZYŃSKI
In Vivo January 2021, 35 (1) 585-591; DOI: https://doi.org/10.21873/invivo.12295
PRZEMYSŁAW GAŁĄZKA
1Department of General and Oncological Surgery for Children and Adolescents Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland;
2Department of Pediatric Hematology and Oncology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: galazkaprzemek@hotmail.com
MAGDALENA CHRZANOWSKA
1Department of General and Oncological Surgery for Children and Adolescents Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAN STYCZYŃSKI
2Department of Pediatric Hematology and Oncology, Nicolaus Copernicus University in Torun, Ludwik Rydygier Collegium Medicum, Bydgoszcz, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The objective of the study was analysis of risk factors associated with outcome of necrotizing enterocolitis (NEC) in infants in a single-center study. Patients and Methods: All consecutive infants hospitalized for NEC over a period of 6 years were retrospectively analyzed for clinical course, infections, treatment and outcome. Results: Out of 76 patients, surgical management was applied in 56 (53 exploratory laparotomy, three initial peritoneal drain placement) and in 20 there was only a conservative approach. Segmental intestinal resection was performed in 41 patients. Survival from NEC in our cohort was 79%. We found that independent adverse risk factors of outcome of newborns and infants with NEC were gut perforation, infection, abdominal wall erythema, and development of acute kidney injury. Conclusion: We underline the value of both surgical and conservative approach with careful management in this cohort of patients.

  • Newborns
  • infants
  • necrotizing enterocolitis
  • minimally invasive surgery

Necrotizing enterocolitis (NEC) is a complex predominantly intestinal inflammatory disorder affecting preterm infants, and the major cause of morbidity and mortality in this age group. It is one of the most common gastrointestinal (GI) emergencies in the neonatal period. NEC has multifactorial etiology and is characterized by a variable degree of intestinal gangrene. Population-based studies have estimated the incidence of NEC between 0.72-1.8 per 1,000 live births (1). Most neonates diagnosed with NEC are at the age of less than 32 weeks of gestation, particularly in the case of extremely low birth weight infants weighing less than 1,000 g, while a decline in incidence occurs after 35 weeks of gestation (2).

Well-known risk factors for development of NEC include prematurity and bacterial colonization of the gastrointestinal tract (3, 4). With increasing survival of extremely premature infants, the number of neonates at risk for developing NEC continues to rise. Clinical features of NEC include the presence of physiological and metabolic instability, abdominal distention, and feeding intolerance (5). Disease severity is characterized by clinical and radiographic findings, known as the Bell staging system (6).

The objective of this study was the analysis of the clinical course and risk factors for outcomes of infants with NEC in a single-center study.

Patients and Methods

Design of the study. A total of 76 consecutive infants including 43 (56.6%) males, and 33 (43.4%) females with NEC hospitalized at the Department over a period of 6 years were retrospectively analyzed for clinical course, infections, treatment and outcome. The study was approved by Collegium Medicum in Bydgoszcz Bioethical Committee No 465/2011.

NEC diagnosis and classification. NEC was diagnosed on the basis of clinical, laboratory (e.g. white blood cell count, neutrophil count, platelet count, blood gas balance, C-reactive protein) and radiological (e.g. ultrasound, X-ray) signs and symptoms. Patients admitted to the Department were treated surgically or conservatively. Surgical treatment was based on laparotomy or peritoneal drainage. The newborns were classified according to Bell’s (6-8) or modified Tepas criteria (9). NEC classification in Bell’s criteria with Walsh-Kliegman modification (6-8) included three stages: Stage I: suspicion of NEC (A, occult GI bleeding; B, GI bleeding); stage II: diagnosed NEC (A, mild; B, intermediate); stage III: advanced NEC (A, without perforation; B, with perforation). Additionally, we classified patients with NEC according to Tepas criteria of NEC natural history (9) with our own modification, which included four grades: Grade 1: no necrosis, no perforation; grade 2: perforation but without metabolic or hematologic derangements; grade 3: severe clinical symptoms with coexisting metabolic and hematological derangements (thrombocytopenia, neutropenia, left shift of segmented neutrophils, metabolic acidosis, hyponatremia, bacteremia, or hypotension) together with free intraperitoneal air; grade 4: severe clinical symptoms with coexisting metabolic and hematological derangements, without free intraperitoneal air.

Statistical analysis. Categorical variables were compared by the chi-square test or Fisher exact test, with odds ratio (OR) and 95% confidence interval (95% CI); and non-categorical variables by the Mann-Whitney test. The primary endpoint of the study was overall survival (OS). The survival curves were determined by the Kaplan–Meier method and compared with log-rank test. Risk factors analysis for surgical treatment were in univariate analysis were by uni- and multivariate logistic regression. Risk factor analysis for survival was performed using a univariate Cox model. Factors significant in univariate model were analyzed in multivariate Cox model. The results of the multivariate analysis are presented by hazard ratio (HR) with a 95% CI. A value of p<0.05 was considered statistically significant. The analysis was performed using the statistical package SPSS 25.0 (IBM, Armonk, NY, USA).

Results

Demographics. The median gestational birth age was 29 weeks (range=23-41 weeks), median weight 1095 g (range=570-4,620 g), median Apgar score 5 (range=1-10), and median age at admission 12 days (range=1-3 days). The distribution of patients according to Bell’s and modified Tepas classifications are shown in Figure 1.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Frequency distribution of patients according to Bell’s classification (6-8) (A) and modified Tepas classification (9) (B).

Microbial colonization. On admission, colonization was diagnosed in 53 patients, including bacterial etiology in 52 patients (Gram-positive in 35, and Gram-negative in 17), and fungal etiology in eight patients. Gram-positive strains detected included: methicillin-resistant coagulase-negative Staphylococcus in nine, Staphyococcus aureus in four, Staphyococcus spp in eight, Staphyococcus epidermidis in two, Staphyococcus haemolyticus in seven, Streptococcus pnuemoniae in one, Streptococcus viridans in two, Enterococcus faecalis in seven, and Enteroccus faecium in seven. Gram-negative strains included: Klebsiella pneumoniae in five, Klebsiella oxytoca in four, Escherichia coli in 14, Enterobacter cloacae in three, Serratia marcescens in one, Citrobacter spp in two, Corynebacterium spp in two, Pseudomonas aeruginosa in one, Acinetobacter baumanii in 2, and Stenotrophomonas maltophilia in four. Fungal colonization included: Candida albicans in six, Candida guilliermondii in one, and Candida faringe in one.

Infectious complications. Infections developed in 51 patients, including sepsis in 48 patients, microbiologically documented infection in 28 patients, and clinically documented infection in 21 patients. Bacterial etiology of infection was diagnosed in 26 patients (Gram-positive in 14, and Gram-negative in 12), and fungal infection in seven patients. Infection with Gram-positive strains included: Staphylococcus epidermidis in nine, Staphylococcus haemolyticus in three, Streptococcus pneumoniae in one, and Enteroccus faecium in one. Infection with Gram-negative strains included: Klebsiella pneumoniae in two, Escherichia coli in four, Enterobacter cloacae in two, Aeromonas spp in one, Acinetobacter baumanii in two, and Stenotrophomonas maltophilia in two. Infections with fungi included: Candida albicans in five, Candida guilliermondii in one, Candida faringe in one, and Candida pelicula in one.

Surgical treatment. Out of 76 patients, 56 were treated surgically (53 exploratory laparoscopy, three peritoneal drain placement) and 20 conservatively only. Intestine resection with concomitant creation of enterostomy was performed in 41 patients, at a median of 12 days (range=1-45 day). Median length of resected intestine was 10 cm (range=3-72 cm). significantly risk factors for surgical treatment in univariate analysis were: Grade 3-4 in modified Tepas classification (HR=5.0, 95% CI=1.6-16, p=0.006), stage III in classification by Bell (HR=28, 95% CI=6.9->100, p<0.001), and perforation (HR=9.9, 95% CI=3.0-32, p<0.001), while birth weight <1,000 g was a factor reducing the decision on surgical treatment (HR=0.20, 95% CI=0.1-0.7, p=0.007). The only risk factor remaining significant for surgical treatment in multivariate analysis was stage III in classification by Bell (HR=40, 95% CI=7.4->100, p<0.001).

Antibiotic utilization. All patients were treated with antibiotics, including: meropenem in 39, imipenem in 13 (carbapenems in 49), vancomycin in 45, teicoplanin in 8, linezolid in one, piperacillin-tazobactam in 12, cephalosporines III/IV generation in 10 (ceftazidime in eight, ceftriaxone in two, cefepime in one), metronidazole in 60, amikacin in 13, netilmicin in 13, gentamicin in one, amoxicillin with clavulanate in 12, cefuroxime in one, cefoperazon with sulbactam in three, ciprofloxacin in three, ampicillin in two, and colistin in two. Overall, 66 patients were administered antifungals, including fluconazole in 61, amphotericin B in three, voriconazole in one, and anidulafungin in one.

Univariate analysis of risk factors for overall survival. Overall, 16 (21%) patients died, at a median of 16 days (range=1-35 days) after admission to the Department. In univariate analysis, the following risk factors significantly contributed to adverse outcome: Grade 3/4 in modified Tepas classification, infection, use of carbapenems, use of glycopeptides, GI hemorrhage, septic shock, acidosis, abdominal wall erythema, intestine perforation, acute kidney injury, age at discharge less than 36 days, and length of hospital stay less than 20 days (Table I).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Univariate analysis of risk factors for overall survival of infants with necrotizing enterocolitis at day 60 after admission to hospital.

Apart from the parameters shown in Table I, also sex, mode of delivery (cesarean section), fungal colonization, Gram-negative bacterial colonization, microbiologically documented infections, specific bacterial strain, other laboratory and radiographic findings, as well as the use of any other antibiotic, had no influence on survival.

Multivariate analysis of risk factors for OS. The following independent factors, significant in univariate Cox analysis were included in the multivariate analysis: Infection, clinically documented infection, GI hemorrhage. septic shock, acidosis, abdominal wall erythema, intra-abdominal fluid, perforation, and acute kidney injury (Table II, Figure 2). On the other hand, the following factors were considered dependent on others: Modified Tepas classification, carbapenem use, age at discharge, and length of stay.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Multivariate analysis of risk factors for overall survival.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Overall survival with respect to concomitant infection (A), abdominal wall rythema (B), perforation (C) and acute kidney injury (AKI) (D).

Four independent factors significantly increased the risk of death due to NEC: Gut perforation, infection, abdominal wall erythema, and the development of acute kidney injury.

Discussion

The major finding of this study was determination of four independent adverse risk factors for outcome of newborns and infants with NEC, namely gut perforation, infection, abdominal wall erythema, and development of acute kidney injury.

Most patients included in the study were treated surgically either by exploratory laparotomy or with peritoneal drainage. In multivariate analysis, we showed that stage III in classification by Bell including perforation was the strongest factor influencing the decision of surgical treatment, while birth weight <1,000 g was the factor determining an initial conservative approach. Lower birth weight is a well-known factor associated with a higher frequency and greater severity of disease (10, 11).

A number of laboratory and radiographic parameters confirmed adverse values of parameters assessing clinical status, and those confirming gut perforation have the highest value in selection of therapeutic approach and outcome of NEC. Obviously, a newborn’s death due to NEC is associated with severe clinical signs, laboratory parameters (leukocytosis, high level of C-reactive protein, metabolic acidosis) and radiological signs (no gas in the digestive tract). Perforation of the GI tract is usually followed by metabolic acidosis and typical radiological signs (free echogenic fluid in peritoneum and free gas in the abdomen). The same symptoms might develop in the case of postsurgical complications, such as acute kidney injury, which is frequently associated with the severity of enterocolitis (12). We also found that abdominal wall erythema was a relatively frequent symptom in our cohort, and had an adverse prognostic value. This phenomenon is rarely described in the literature, and it might be included in symptoms of abdominal distension (13).

In our cohort, a classic surgical treatment of NEC was applied: Resection of the necrotic bowel segment together with temporary proximal enterostomy creation. Nowadays several options for surgical treatment are proposed, depending mainly on the extent of necrosis and the patient’s general status (14, 15). In an experimental model, it has been shown that laparoscopy has acceptable levels of agreement with laparotomy in NEC lesions of both the colon and the small intestine (16). There is still an open question of the use of minimally invasive surgery in neonates and small infants (14-16).

We previously showed that in case of congenital abdominal cystic lesions, a laparoscopically assisted minimal-access approach resulted in minimal risk of complications and complete recovery in all patients (17). On the other hand, a completely different approach was necessary for patients with Hirschsprung’s disease (18).

This study has some limitations. Apart from its retrospective design and long-term inclusion as a single-center study, we also did not analyze factors which may have contributed to the development of NEC, including the general care of newborns, such as antenatal corticosteroid use, delayed enteral feeding, human milk feeding, and pre- or probiotic administration (19). On the other hand, we analyzed a large number of risk factors, including clinical classifications, clinical signs and symptoms, laboratory and imaging parameters both in diagnosis of NEC and in the selection of treatment approach; however, no other independent factors were found which contributed to OS. The use of specific antibiotics, including carbapenems and glycopeptides, was bound to worsen survival, however, this was because of severe infection which required these ‘reference’ antibiotics and not any negative impact of the antibiotics themselves.

In conclusion, survival from NEC in our cohort was 79%. We found that independent adverse risk factors of outcome of NEC in newborns and infants were gut perforation, systemic infection, abdominal wall erythema, and the development of acute kidney injury. We underline the value of both surgical and conservative approach with careful management in this cohort of patients. The role of minimally invasive surgery in NEC might be a question of future research.

Footnotes

  • Authors’ Contributions

    PG: Concept/design, data analysis/interpretation, writing article; PG, MC, and JS: data collection, data analysis/interpretation; PG and JS: critical revision of article, approval of article.

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors have no conflicts of interest to disclose in regard to this study.

  • Received October 25, 2020.
  • Revision received November 4, 2020.
  • Accepted November 10, 2020.
  • Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Holcomb GW III.,
    2. Murphy JP and
    3. Ostlie DJ
    1. Dominguez KM and
    2. Moss RL
    : Necrotizing enterocolitis. In: Ashcraft’s Pediatric Surgery Sixth Edition. Holcomb GW III., Murphy JP and Ostlie DJ (eds.). London, Elsevier-Saunders, pp. 454-67, 2014.
  2. ↵
    1. Patel RM,
    2. Knezevic A,
    3. Shenvi N,
    4. Hinkes M,
    5. Keene S,
    6. Roback JD,
    7. Easley KA and
    8. Josephson CD
    : Association of red blood cell transfusion, anemia, and necrotizing enterocolitis in very low-birth-weight infants. JAMA 315(9): 889-897, 2016. PMID: 26934258. DOI: 10.1001/jama.2016.1204
    OpenUrlCrossRefPubMed
  3. ↵
    1. Sjoberg Bexelius T,
    2. Ahle M,
    3. Elfvin A,
    4. Bjorling O,
    5. Ludvigsson JF and
    6. Andersson RE
    : Intestinal failure after necrotising enterocolitis: Incidence and risk factors in a Swedish population-based longitudinal study. BMJ Paediatr Open 2(1): e000316, 2018. PMID: 30613802. DOI: 10.1136/bmjpo-2018-000316eCollection2018
    OpenUrlCrossRef
  4. ↵
    1. Han SM,
    2. Hong CR,
    3. Knell J,
    4. Edwards EM,
    5. Morrow KA,
    6. Soll RF,
    7. Modi BP,
    8. Horbar JD and
    9. Jaksic T
    : Trends in incidence and outcomes of necrotizing enterocolitis over the last 12 years: A multicenter cohort analysis. J Pediatr Surg 55(6): 998-1001, 2020. PMID: 32173122. DOI: 10.1016/j.jpedsurg.2020.02.046
    OpenUrlCrossRef
  5. ↵
    1. Heida FH,
    2. Stolwijk L,
    3. Loos MH,
    4. van den Ende SJ,
    5. Onland W,
    6. van den Dungen FA,
    7. Kooi EM,
    8. Bos AF,
    9. Hulscher JB and
    10. Bakx R
    : Increased incidence of necrotizing enterocolitis in the Netherlands after implementation of the new Dutch guideline for active treatment in extremely preterm infants: Results from three academic referral centers. J Pediatr Surg 52(2): 273-276, 2017. PMID: 27923478. DOI: 10.1016/j.jpedsurg.2016.11.024
    OpenUrlCrossRef
  6. ↵
    1. Bell MJ,
    2. Ternberg JL,
    3. Feigin RD,
    4. Keating JP,
    5. Marshall R,
    6. Barton L and
    7. Brotherton T
    : Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187(1): 1-7, 1978. PMID: 413500. DOI: 10.1097/00000658-197801000-00001
    OpenUrlCrossRefPubMed
    1. Bell MJ
    : Neonatal necrotizing enterocolitis. N Engl J Med 298(5): 281-282, 1978. PMID: 619275.
    OpenUrlPubMed
  7. ↵
    1. Walsh MC and
    2. Kliegman RM
    : Necrotizing enterocolitis: Treatment based on staging criteria. Pediatr Clin North Am 33(1): 179-201, 1986. PMID: 3081865. DOI: 10.1016/s0031-3955(16)34975-6
    OpenUrlCrossRefPubMed
  8. ↵
    1. Tepas JJ, 3rd.,
    2. Sharma R,
    3. Hudak ML,
    4. Garrison RD and
    5. Pieper P
    : Coming full circle: An evidence-based definition of the timing and type of surgical management of very low-birth-weight (<1,000 g) infants with signs of acute intestinal perforation. J Pediatr Surg 41(2): 418-422, 2006. PMID: 16481262. DOI: 10.1016/j.jpedsurg.2005.11.041
    OpenUrlCrossRefPubMed
  9. ↵
    1. Wang ZL,
    2. An Y,
    3. He Y,
    4. Hu XY,
    5. Guo L,
    6. Li QY,
    7. Liu L and
    8. Li LQ
    : Risk factors of necrotizing enterocolitis in neonates with sepsis: A retrospective case–control study. Int J Immunopathol Pharmacol 34: 2058738420963818, 2020. PMID: 33016797. DOI: 10.1177/2058738420963818
    OpenUrlCrossRef
  10. ↵
    1. Quiroz HJ,
    2. Rao K,
    3. Brady AC,
    4. Hogan AR,
    5. Thorson CM,
    6. Perez EA,
    7. Neville HL and
    8. Sola JE
    : Protocol-driven surgical care of necrotizing enterocolitis and spontaneous intestinal perforation. J Surg Res 255: 396-404, 2020. PMID: 32615312. DOI: 10.1016/j.jss.2020.05.079
    OpenUrlCrossRef
  11. ↵
    1. Sanchez C,
    2. Garcia MA and
    3. Valdes BD
    : Acute kidney injury in newborns with necrotizing enterocolitis: Risk factors and mortality. Bol Med Hosp Infant Mex 76(5): 210-214, 2019. PMID: 31536045. DOI: 10.24875/BMHIM.19000044
    OpenUrlCrossRef
  12. ↵
    1. Meister AL,
    2. Doheny KK and
    3. Travagli RA
    : Necrotizing enterocolitis: It’s not all in the gut. Exp Biol Med 245(2): 85-95, 2020. PMID: 31810384. DOI: 10.1177/1535370219891971
    OpenUrlCrossRef
  13. ↵
    1. Smith J and
    2. Thyoka M
    : What role does laparoscopy play in the diagnosis and immediate treatment of infants with necrotizing enterocolitis? J Laparoendosc Adv Surg Tech A 23(4): 397-401, 2013. PMID: 23573887. DOI: 10.1089/lap.2012.0482
    OpenUrlCrossRefPubMed
  14. ↵
    1. Galazka P,
    2. Czyzewski K,
    3. Marjanska A,
    4. Daniluk-Matras I and
    5. Styczynski J
    : Minimally invasive surgery in pediatric oncology: Proposal of guidelines. Anticancer Res 39(11): 5853-5859, 2019. PMID: 31704809. DOI: 10.21873/anticanres.13789
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Knudsen KBK,
    2. Thorup J,
    3. Thymann T,
    4. Strandby R,
    5. Nerup N,
    6. Achiam MP,
    7. Lauritsen T,
    8. Svendsen LB,
    9. Buelund L,
    10. Sangild PT and
    11. Ifaoui IBR
    : Laparoscopy to assist surgical decisions related to necrotizing enterocolitis in preterm neonates. J Laparoendosc Adv Surg Tech A 30(1): 64-69, 2020. PMID: 31874058. DOI: 10.1089/lap.2018.0180
    OpenUrlCrossRef
  16. ↵
    1. Galazka P,
    2. Redloch K,
    3. Kroczek K and
    4. Styczynski J
    : Minimally invasive surgery for congenital abdominal cystic lesions in newborns and infants. In Vivo 34(3): 1215-1221, 2020. PMID: 32354912. DOI: 10.21873/invivo.11895
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Galazka P,
    2. Szylberg L,
    3. Bodnar M,
    4. Styczynski J and
    5. Marszalek A
    : Diagnostic algorithm in Hirschsprung’s disease: Focus on immunohistochemistry markers. In Vivo 34(3): 1355-1359, 2020. PMID: 32354930. DOI: 10.21873/invivo.11913
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Zhang B,
    2. Xiu W,
    3. Dai Y and
    4. Yang C
    : Protective effects of different doses of human milk on neonatal necrotizing enterocolitis. Medicine 99(37): e22166, 2020. PMID: 32925782. DOI: 10.1097/MD.0000000000022166
    OpenUrlCrossRef
View Abstract
PreviousNext
Back to top

In this issue

In Vivo: 35 (1)
In Vivo
Vol. 35, Issue 1
January-February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Spectrum and Outcomes of Neonatal Necrotizing Enterocolitis
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Spectrum and Outcomes of Neonatal Necrotizing Enterocolitis
PRZEMYSŁAW GAŁĄZKA, MAGDALENA CHRZANOWSKA, JAN STYCZYŃSKI
In Vivo Jan 2021, 35 (1) 585-591; DOI: 10.21873/invivo.12295

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinical Spectrum and Outcomes of Neonatal Necrotizing Enterocolitis
PRZEMYSŁAW GAŁĄZKA, MAGDALENA CHRZANOWSKA, JAN STYCZYŃSKI
In Vivo Jan 2021, 35 (1) 585-591; DOI: 10.21873/invivo.12295
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer
  • A Finnish Version of RAND-36-Item Health Survey Versus Structured Interview 8 Years Postoperatively
  • Cytotoxic T-lymphocyte Antigen-4 (CTLA-4) Gene Polymorphism (rs3087243) Is Related to Risk and Survival in Patients With Colorectal Cancer
Show more Clinical Studies

Similar Articles

Keywords

  • Newborns
  • infants
  • necrotizing enterocolitis
  • minimally invasive surgery
In Vivo

© 2021 In Vivo

Powered by HighWire